Grow your business safely with EYDO PHARMA

All the information you need about EYDO PHARMA to develop and secure your business in France

E HOME > CORPORATES > EYDO PHARMA > BALANCE SHEET ( 2019-07-19)

THE LIST OF BALANCE SHEET : EYDO PHARMA

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2020-10-28 Public 2019-12-31 Complete
2019-07-19 Public 2018-12-31 Complete
2018-06-26 Public 2017-12-31 Complete
2017-11-23 Public 2016-12-31 Complete
NameEYDO PHARMA
Siren453606626
Closing2018-12-31
Registry code 2801
Registration number B2019/003685
Management number2014B00308
Activity code 2053Z
Closing date n-12017-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2019-07-19
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address28000 CHARTRES
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 82 008.00 74 068.00 7 940.00 82 008.00
AF Concessions, Patents and Similar Rights 1 136 008.00 932 008.00 204 001.00 1 136 008.00
AH Goodwill 159 150.00 159 150.00 159 150.00
AJ Other Intangible Assets 200 000.00 200 000.00 200 000.00
AT Other tangible assets 18 310.00 18 310.00 18 310.00
BB Receivables related to investments 153.00 153.00 153.00
BH Other financial assets 192.00 192.00 192.00
BJ TOTAL (I) 3 247 720.00 2 164 230.00 1 083 490.00 3 247 720.00
BX Customers and related accounts 14 479.00 14 479.00 14 479.00
BZ Other receivables 121 360.00 121 360.00 121 360.00
CF Cash and cash equivalents 60 351.00 60 351.00 60 351.00
CH Prepaid expenses 400.00 400.00 400.00
CJ TOTAL (II) 196 590.00 196 590.00 196 590.00
CO Grand total (0 to V) 3 444 309.00 2 164 230.00 1 280 080.00 3 444 309.00
CX Development or Research and Development Expenses 1 651 899.00 780 694.00 871 205.00 1 651 899.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 864 370.00 864 370.00 864 370.00
DC Revaluation differences 4 427 286.00 4 427 286.00 4 427 286.00
DH Retained earnings -6 108 711.00 -5 774 989.00 -6 108 711.00
DI RESULTS FOR THE YEAR (Profit or Loss) -725 205.00 -333 721.00 -725 205.00
DL TOTAL (I) -1 542 259.00 -817 054.00 -1 542 259.00
DN Conditional advances 1 159 535.00 1 159 865.00 1 159 535.00
DO TOTAL (II) 1 159 535.00 1 159 865.00 1 159 535.00
DP Provisions for Risks 65 833.00 51 000.00 65 833.00
DR TOTAL (IV) 65 833.00 51 000.00 65 833.00
DS Convertible Bond Issues 199 980.00 199 980.00 199 980.00
DU Loans and Debts from Credit Institutions (3) 13 452.00 14 258.00 13 452.00
DV Miscellaneous Loans and Financial Debts (4) 99 292.00 20 145.00 99 292.00
DX Trade payables and related accounts 716 571.00 761 154.00 716 571.00
DY Tax and social security liabilities 267 346.00 179 978.00 267 346.00
EA Other liabilities 300 330.00 555.00 300 330.00
EC TOTAL (IV) 1 596 971.00 1 176 070.00 1 596 971.00
EE Grand total (I to V) 1 280 080.00 1 569 881.00 1 280 080.00
EG Accrued income and payables due within one year 1 596 971.00 1 176 070.00 1 596 971.00
EH Including current bank overdrafts and credit balances from banks and postal accounts 2 810.00 2 810.00 2 810.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FD Production sold - goods 1 689.00
FJ Net sales 1 689.00
FP Reversals of depreciation and provisions, transfer of expenses 54.00
FR Total operating income (I) 1 743.00
FU Purchases of raw materials and other supplies 490.00
FW Other purchases and external expenses 76 448.00
FX Taxes, duties, and similar payments 1 733.00
FY Salaries and Wages
FZ Social Security Contributions
GA Operating Expenses - Depreciation and Amortization 252 581.00
GE Other Expenses
GF Total Operating Expenses (II) 331 252.00
GG - OPERATING RESULT (I - II) -329 509.00
GN Positive exchange differences 2 648.00
GP Total financial income (V) 2 648.00
GR Interest and similar expenses 12.00
GU Total financial expenses (VI) 12.00
GV - FINANCIAL INCOME (V - VI) 2 636.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -326 873.00
4 - Income statement (continued)Amount year NAmount year N-1
HD Total exceptional income (VII) 165 220.00 10.00 165 220.00
HH Total exceptional expenses (VIII) 563 552.00 2 554.00 563 552.00
HI - EXCEPTIONAL RESULT (VII - VIII) -398 332.00 -2 544.00 -398 332.00
HL TOTAL REVENUE (I + III + V + VII) 169 611.00 13 226.00 169 611.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 894 816.00 346 947.00 894 816.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -725 205.00 -333 721.00 -725 205.00

all companies in France

Complete and comprehensive database.